In our hands, these data support the idea that DNA methylation at the promoter region of the PRLHR receptor and the likely decline of its expression could be involved, in conjunction with PrRP, in the buildup of AD signature proteins in the hippocampus, a brain region most vulnerable to AD. The gene discussed is PRLH; the disease is Alzheimer disease.